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ABSTRACT 
Objective: The present study was designed to demonstrate the antioxidant, hypolipidemic and hypoglycaemic potentials of aqueous extract of O. 
corymbosa against alloxan-induced diabetes in rats.  
Methods: O. corymbosa extract was tested for phytochemical screening, total phenolic, flavonoids content and DPPH free radical scavenging activity. 
Diabetes was induced in Sprague Dawley rats by administration of alloxan monohydrate (65 mg/kg b. w i. v). The aqueous extract of O. corymbosa at 
a dose of 100 mg/kg and 200 mg/kg were administered through gavage feeding daily to diabetic induced rats for 14 d. The effect of aqueous extract 
of O. corymbosa was assessed on blood glucose, body weight, lipid peroxidation, catalase activity, glutathione and lipid profile. Pancreatic tissues 
were also examined by haematoxylin and eosin staining methods. 
Results: Phytochemical screening shows the presence of tannins, saponins, phlobatannins and flavonoids. Total phenolic content was found to be 
22.85±0.21 mg/g, IC50 is 450±1.39 µg/ml and total flavonoids content was found to be 4.25±0.09 mg/g of extract. The results of the present study 
showed that O. corymbosa can lower blood glucose and lipid parameters except for HDL. The levels of antioxidant enzymes CAT and GSH were 
increased along with the decreased in LPO level by the pre-treatment of animals with O. corymbosa. Microscopic examination of pancreatic sections 
revealed that diabetic rats treated with O. corymbosa extracts at either dose have normal architecture structure of islets.  
Conclusion: These results indicate that O. corymbosa may be effective as a hypoglycaemic and antihyperlipidemic agent.  
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INTRODUCTION 
Diabetes mellitus has affected the lives of many people from around 
the world suffering from it and Malaysia has 3.2 million cases of 
diabetes reported in the year 2014 alone [1]. The word diabetes 
means a condition of a person which secretes out “sweet urine” and 
also experiences a major loss of muscle which is due to a condition 
known as hyperglycaemia where the level of blood glucose increases, 
thus causes the spillage of glucose into the urine. Hyperglycaemia is 
caused by the absence or insufficient amount of insulin produced in 
the body [2] and this condition is the landmark of diabetes [3]. There 
are two types of diabetes which are type 1 and type 2. Patients with 
type 1 diabetes cannot produce insulin thus Type 1 diabetes is also 
known as insulin-dependent or juvenile-onset. On the other hand, 
patients with Type 2 diabetes or also known as non-insulin-dependent 
or adult-onset can produce insulin however the insulin produced 
cannot convert the food into energy [4].  
Diabetes is currently treated by using insulin and oral hypoglycaemic 
agents which has recorded huge successes in addition to the 
adjustment of lifestyle [5]. However, treating diabetes with insulin or 
oral hypoglycaemic agents comes with several serious side effects 
such as recurrent cases of hypoglycaemic coma [5]. Besides that, 
diabetes patients are facing the risks of impairment of hepatic and 
other body functions with every shot of insulin they take [3]. These 
two medications are therefore not sufficient in preventing diabetic 
complications. Due to the problems associated with the current 
treatments, scientists have now looking for alternative remedies from 
potential plants. There are more than 800 plant species from around 
the world that have been used as a treatment for diabetes and proven 
to have antihyperglycemic activity [6]. Thompson Coon and Earnst [7] 
stated that there are several plants that have additional potentials 
such as ameliorate the abnormalities of lipid metabolism besides 
correcting the blood glucose levels in diabetes patients. The significant 
of research on medicinal plants is validated by the fact that many types 
of new drugs have been developed from plants, for example, Galega 
officinalis L. which is used to synthesis metformin as well as other 
bisguanidine-type anti-diabetic drugs [8]. Biologically active 
compounds in plants are recommended to be used to reduce the 
number of diabetes complications and also delaying their 
development [9].  
O. corymbosa Linn or also known as Hedyotis corymbosa (L.) Lam is 
from the Rubiaceae family [10]. O. corymbosa is generally called as 
“Rumput mutiara” and it is said that the whole O. coymbosa plant 
(leaves, stem, roots, flowers and seeds) can be used as medicine [10]. 
According to Endrini [10], O. corymbosa has been reported to have 
many medicinal values such as for the treatment of jaundice [11]. 
Besides that, O. corymbosa has anticancer activity and high antioxidant 
activities and also contains flavonoids and phenolic compounds [10]. 
O. corymbosa is also used traditionally in India and China to treat 
hepatic disorders [12]. Therefore, it is worth conducting research 
work on O. corymbosa to find out whether or not it has anti-diabetic 
activity since it shows many potentially bioactive compounds that may 
play important roles in anti-diabetic activities. 
MATERIALS AND METHODS 
Chemicals and reagents 
Alloxan monohydrate, 1,2-dithio-bis-nitrobenzoic acid (DTNB), 
bovine serum albumin (BSA), folin-ciocalteu reagent (FCR), 
thiobarbituric acid (TBA), hydrogen peroxide (H2O2), sulfosalicylic 
acid (SSA), gallic acid, catechin, 1,1-diphenyl-2-picrylhydrazyl 
(DPPH), haematoxylin, eosin and trichloroacetic acid (TCA) were 
purchased from Sigma-Aldrich Chemical Company, USA. All other 
solvents and chemicals used were either of analytical grade or of the 
highest purity commercially available. 
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Collection of plant  
O. corymbosa plant was collected from Universiti Malaysai Sabah. 
The plant sample was identified based on morphological 
characteristics (voucher number: Caysandra 01) by Mr. Johnny Gisil, 
a botanist from Institut Biologi Tropika dan Pemuliharaan, 
Universiti Malaysia Sabah.  
Preparation of plant extract 
The whole plant of O. corymbosa (except roots) were washed under 
running tap water to remove dirt and foreign materials. The whole 
plant of O. corymbosa (except roots) were then dried under shade for 3 
to 4 w. After the plant sample had been dried completely under a 
shade, the sample was then crushed into a coarse powder using heavy-
duty blender and placed in air tight containers. Next, the aqueous 
extraction of plant sample was prepared following Yuan et al. [13].  
Phytochemical screening 
For the identification of the constituents present in the O. corymbosa, 
the extract obtained was subjected to six qualitative tests which are 
tannins, phlobatannins, saponins, flavonoids, terpenoids, and cardiac 
glycosides according to methods reported by Krishnaiah et al. [14]. 
Determination of total phenolic content 
The total phenols in aqueous extract of O. corymbosa were estimated 
by Folin-Ciocalteu’s phenol reagent according to Shingleton et al. 
[15] expressed as milligram gallic acid equivalents (GAE) per gram 
dry weight of the extract.  
Determination of antioxidant activity 
The ability of plant extract to scavenge DPPH free radicals was 
determined according to Hatano et al. [16] method.  
Determination of total flavonoids content 
Total flavonoids content in O. corymbosa plant extract was measured 
by aluminium chloride colourimetric assay [13]. Total flavonoid 
content was expressed in milligrams of catechin equivalents per 
gram of plant extract. 
Sprague-Dawley rats  
Animal study was approved by Animal Ethics Committee (AEC) of 
Universiti Malaysia Sabah. Twenty four male Sprague-Dawley rats 
weighing between 150 g-300 g and age between 6 to 12 w old were 
purchased from Fakulti Sains Makanan dan Pemakanan, Universiti 
Malaysia Sabah. All 24 rats were placed in Animal Biosafety 
Laboratory of Biotechnology Research Institute, Universiti Malaysia 
Sabah, in colony plastic cages and provided with water ad libitum 
and standard food pellet. The rats were put under 12-hour light and 
12-hour dark cycles with 24-28 °C temperature. One week time was 
given to allow the rats to adapt to the environment.  
Experimental design 
After an overnight fast with water provided, the rats were then 
made diabetic by intravenously injecting alloxan monohydrate, 65 
mg/kg body weight [17] dissolved in normal saline as reported by 
Kumar et al. [18] (Alloxan; Sigma Co., St. Louis, USA). Rats in the 
control group were only injected with normal saline. Blood from 
each rat was taken from the lateral veins of the tail and the blood 
sugar levels were then subjected to a glucometer to read the blood 
sugar level. Only rats with blood sugar level more than 200 mg/dl 
(diabetic) were used in the experiment. The rats were put into five 
groups randomly with three rats per group (n=3). The blood glucose 
levels and body weight of each rat in each group were measured 
weekly for two weeks. The rats were sacrificed at the 15th day by 
first anaesthetizing them, 24 h after their respective daily dosages.  
Group 1: Normal rats administered normal saline (normal control) 
Group 2: Diabetic rats administered with normal saline (diabetic control) 
Group 3: Normal rats administered with O. corymbosa (200 mg/kg b. wt) 
Group 4: Diabetic rats treated with O. corymbosa (100 mg/kg b. wt) 
Group 5: Diabetic rats treated with O. corymbosa (200 mg/kgb. wt) 
The weight of all treated rats was determined by using a physical 
balance (Sartorius, 6202-1S) before and after treatment. The rats 
were sacrificed at the 15th day after their last doses of plant extracts 
by cervical dislocation and were first anaesthetized by using light 
ether. After that, the rats’ pancreases were dissected out quickly. 
Extraneous material was cleaned from the pancreases and washed 
with ice-cold saline (0.85% w/v, sodium chloride) and then dipped 
in 0.1M, pH 7.4 phosphate buffer and later stored at-80 Cͦ for further 
biochemical and histopathological investigations. 
Collection of blood 
The blood sample of each rat was collected by using cardiac 
punctures technique after cervical dislocation before their heart-
beats stop. The blood samples were collected in separated BD 
Vacutainer® Blood Collection Tubes and later centrifuged at 1375 x 
g for 30 min and the serum was separated.  
Post mitochondrial supernatant preparation 
The pancreases of the animal in every group were washed immediately 
in ice-cold saline (0.85% w/v, sodium chloride). After that, the 
pancreases of rats were homogenized in a chilled phosphate buffer (0.1 
M, pH 7.4) containing KCI (1.17 % w/v, potassium chloride) using a 
homogenizer (Polytron PT 1200E). The homogenate sample was 
centrifuged at 2000 x g for 10 min at 4 °C to separate nuclear debris. 
Next, the supernatant obtained was centrifuged again at 10,000 x g for 
30 min at 4 °C to obtain post-mitochondrial supernatant which was used 
for determination of malondialdehyde and reduced glutathione content. 
The supernatant obtained was kept in-80 °C before further analysis.  
Determination of reduced glutathione  
Reduced glutathione was determined by using the method described by 
Jollow et al. [19]. The yellow colour was developed indicating reduced 
glutathione and was read at 412 nm using a spectrophotometer. The 
result was expressed as micromoles of GSH/gram of tissues by using a 
molar extinction coefficient of 13.6 x 103M-1 cm-1. 
Determination of lipid peroxidation  
Lipid peroxidation was measured using the method reported by 
Buege and Aust [20]. The absorbance was measured using a 
spectrophotometer with a wavelength of 535 nm. The results were 
expressed as the amount of MDA formed in each of the samples by 
using a molar extinction coefficient of 1.56 x 105 M-1 cm-1.  
Determination of catalase activity 
Catalase activity was carried out using the Claiborne [21] method with 
slight modification. The changes in absorbance were recorded at 240 nm 
for every 30 seconds for 3 min using a spectrophotometer and the 
enzyme activity was calculated as nmol H2O2 consumed/min/mg protein 
by using a molar extinction coefficient of 6.4 x 103 M-1 cm-1. 
Determination of total protein content 
Total protein contents were determined by Lowry assay using Folin-
Ciocalteau reagent [22].  
Determination of total cholesterol  
The serum concentration of total cholesterol was measured using 
Chod-Pap method as described in instruction provided with the kit 
(BIOLABO, France). 
Determination of high-density lipoprotein cholesterol  
The serum concentration of high-density lipoprotein cholesterol was 
measured using the direct method as described in instruction 
provided with the kit (BIOLABO, France). 
Determination of low-density lipoprotein cholesterol  
The serum concentration of low-density lipoprotein cholesterol was 
measured using the direct method as described in instruction 
provided with the kit (BIOLABO, France). 
Histopathological examination  
The pancreases of sacrificed rats were removed and immediately 
immersed in 10% phosphate-buffered formalin solution. Before the 
Iqbal et al. 
Int J Pharm Pharm Sci, Vol 12, Issue 10, 34-40 
36 
 
embedding process in paraffin wax, the tissues were first processed 
using a tissue processing machine with the standard procedure. The 
tissue sample was first embedded with paraffin wax. After that, the 
specimens were cut into 5 µm thick sections and then immediately 
mounted on the slide for haematoxylin and eosin staining (H and E). 
The specimens were evaluated for degree of haemorrhage, edema, 
necrosis, inflammation and other changes.  
Statistical analysis 
All results were expressed as mean±SD. The results were analysed 
for statistical significance by one-way analysis of variance (ANOVA) 
followed by Dunnett t-test multiple comparison using SPSS 
statistical analysis software. A p-value less than 0.05 is considered 
statistically significant.  
RESULTS 
Phytochemical screening (qualitative analysis) 
O. corymbosa showed the presence of tannins, saponins, 
phlobatannins and flavonoids. Terpenoids and cardiac glycosides 
were not detected. The results obtained from phytochemical 
screening are summarized in table 1 where (+) sign indicates the 
presence of the bioactive compound and (-) sign indicates the 
absence of the bioactive compound. 
  
Table 1: Phytochemical constituents of O. corymbosa 
Constituents Test O. corymbosa  
Tannins  +  
Phlobatannins  +  
Saponins  +  
Flavonoids  +  
Terpenoids  -  
Cardiac glycosides  -  
Key = (+) present; (-) absent 
 
Total phenolic content  
The total phenols of O. corymbosa which was found to be 22.85±0.21 
mg/100 g expressed as milligram gallic acid equivalents (GAE) per 
gram dry weight of the extract.  
Antioxidant activity using 2, 2-diphenyl-2-picrylhydrazyl 
(DPPH)  
The antioxidant activity of free radical scavenging activity of O. 
corymbosa was determined using DPPH assay as shown in table 2. 
Ascorbic acid was used as a reference standard to determine the 
antioxidant potential of O. corymbosa. 
Total flavonoid content 
The concentration of flavonoids in O. corymbosa was found to be 
4.25±0.09 mg/g expressed in terms of catechin equivalent, mg/g of 
extract.  
Blood glucose levels in rats 
Blood glucose levels in rats (5 groups; 3 rats per group) were 
monitored and recorded since day-4 for pre-treatment until day 15, 
the last day of treatment. Blood glucose levels in rats are summarized 
in table 3. The blood glucose level in diabetic rats showed significant 
P<0.05 increment as compared to normal control rats. 
  
Table 2: IC50 values of O. corymbosa by free radical scavenging method 
Sample Radical scavenging activity (DPPH) IC50 (µg/ml) 
Ascorbic acid 15.52±0.59 
O. corymbosa 450±1.39 
Data are presented as mean±SD of three replicates. 
 
Table 3: Effect of aqueous extract of O. corymbosa on blood glucose levels (mg/dl) in rats 
Group 
(n=3) 
Treatment Blood glucose levels (mg/dl) 
-4 d 0th d  3rd d 7th d 14th d 
I Normal control 64.33±13.61 62.67±7.09 76.67±8.5 70.33±10.02 75±19.08 
II Diabetic control 63.67±16.86 60±9.85 241±24.56* 248.67±26.5* 313.33±27.47* 
III Normal+O. corymbosa (200 mg/kg) 73±17.52 68.33±5.69 70.67±4.73** 69.33±7.77** 79.33±10.26** 
IV Diabetic+O. corymbosa (100 mg/kg) 63±12.12 56±7.55 293±26.91* 250.33±27.15* 120.67±26** 
V Diabetic+O. corymbosa (200 mg/kg) 74±18.73 53.67±32.88 296±23.39* 122.33±31.09** 93±14.42** 
Data are presented as mean±SD, Group 2 was compared with Group 1, Groups 3-5 were compared with Group 2, *Significant value at P<0.05 
compared to Normal control, **Significant value at P<0.05 compared to Diabetic control 
 
Table 4: Body-weight changes in rats 
Group 
(n=3) 
Treatment Body-weight (Kg) 
-4 d 0th d 3rd d 7th d 14th d 
I Normal control 104.2±11.58 111.03±5.5 122.03±7.8 131.03±5.72 145.6±9.96 
II Diabetic control 136.6±30.31* 146.07±23.29* 139.1±19.56* 141.47±16.85* 133.59±18.99* 
III Normal+O. corymbosa (200 mg/kg) 116.23±20.99 110.83±19.88 116.2±20.69 124±19.18 125.43±19.69 
IV Diabetic+O. corymbosa (100 mg/kg) 129.97±32.16** 128.83±28.29** 121.97±30.00** 126.6±24.2** 131.2±25.29** 
V Diabetic+O. corymbosa (200 mg/kg) 127.8±27.5** 132.03±19.51** 126.47±16.97** 128.5±19.85** 132.1±22.6** 
Data are presented as mean±SD, *Significant value at P<0.05 compared to Normal control, **Significant value at P<0.05 compared to Diabetic control 
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Body-weight changes in rats 
Body-weight of rats (5 groups; 3 rats per group) was monitored and 
recorded since day-4 for pre-treatment until day 15, the last day of 
treatment. Body-weight changes of the rats are summarized in table 
4. Body-weight of all rats showed steady increment from day-4 till 
day 0. All rats that were induced with alloxan monohydrate, 65 
mg/kg b.w., intravenously showed a decrease in appetite and weight 
loss after 3 d of induction. 
Lipid peroxidation  
As shown in table 5, the lipid peroxidation value was the highest in 
the diabetic control group (97.77±2.23 nmol MDA/g of tissue). 
Alloxan-induced diabetic rats in group IV and V which received O. 
corymbosa extracts (100 mg/kg and 200 mg/kg respectively) 
showed the lipid peroxidation levels were significantly reduced and 
no indicated-any significant difference with the rats in the normal 
control group. 
 
Table 5: Effect of treatment of alloxan-induced diabetic rats with aqueous extract of O. corymbosa for 14 d on lipid peroxide 
Group  (n=3) Treatment Lipid peroxidation (nmol MDA/gram of tissue) 
I Normal control 70.03±2.08 
II Diabetic control 97.77±2.23* 
III Normal+O. corymbosa (200 mg/kg) 75.01±1.61** 
IV Diabetic+O. corymbosa (100 mg/kg) 73.49±1.53** 
V Diabetic+O. corymbosa (200 mg/kg) 72.52±1.24** 
Data are presented as mean±SD, *Significant value at P<0.05 compared to Normal control, **Significant value at P<0.05 compared to Diabetic control 
 
Reduced glutathione  
Glutathione (GSH) acts as a free radical scavenger and also involved in 
the repairmen of damages caused by free radical. GSH is the heart of all 
immune functions where it acts as the body’s master antioxidant. The 
values of GSH in alloxan treated and animals that were treated with O. 
corymbosa treated with alloxan are summarized in table 6. Glutathione 
value was found lowest in the diabetic control group 5.22±0.24 µmol 
GSH/g of tissue. Alloxan-induced diabetic rats in Group IV and V which 
received O. corymbosa extracts (100 mg/kg and 200 mg/kg 
respectively) showed the GSH levels increased slightly from the GSH 
value of diabetic control group. 
  
Table 6: Effect of treatment of alloxan-induced diabetic rats with aqueous extract of O. orymbosa for 14 d on glutathione 
Group (n=3) Treatment GSH (µmol GSH/g of tissue) 
I Normal control 10.62±1.49 
II Diabetic control 5.22±0.24* 
III Normal+O. corymbosa (200 mg/kg) 9.83±0.07** 
IV Diabetic+O. corymbosa (100 mg/kg) 6.43±0.19* 
V Diabetic+O. corymbosa (200 mg/kg) 7.52±0.36** 
Data are presented as mean±SD, *Significant value at P<0.05 compared to Normal control, **Significant value at P<0.05 compared to Diabetic control 
 
Catalase activity 
The values of catalase activity on the treated rats are summarized in 
table 7. Catalase activity was found to be lowest in the diabetic 
control group was found to be 10.72±0.99 U H2O2 
consumed/min/mg protein. Alloxan-induced diabetic rats in Group 
IV and V which received O. corymbosa extracts (100 mg/kg and 200 
mg/kg respectively) showed the catalase activities were significantly 
increased and not indicated any significant difference with the rats 
in the normal control group. 
 
Table 7: Effect of treatment of alloxan-induced diabetic rats with aqueous extract of O. corymbosa for 14 d on catalase 
Group (n=3) Treatment CAT (U H2O2 consumed/min/mg protein) 
I Normal control 25.17±0.65 
II Diabetic control 10.72±0.99* 
III Normal+O. corymbosa (200 mg/kg) 22.18±0.28** 
IV Diabetic+O. corymbosa (100 mg/kg) 21.87±0.18** 
V Diabetic+O. corymbosa (200 mg/kg) 25.35±0.27** 
Data are presented as mean±SD, *Significant value at P<0.05 compared to Normal control, **Significant value at P<0.05 compared to Diabetic control 
 
Total cholesterol, LDL and HDL 
Total cholesterol, LDL and HDL are expressed in mg/dl and the 
results obtained are shown in table 8. Total cholesterol was the 
highest in the diabetic control group with a total cholesterol value 
152.49±0.95 mg/dl. Groups IV and V which received treatment of 
plant extracts of 100 mg/kg and 200 mg/kg respectively showed 
lower total cholesterol as compared to the diabetic control group. 
Similarly, LDL was the highest in the diabetic control group with LDL 
value of 165.83±1.00 mg/dl. Groups IV and V which received 
treatment of plant extracts of 100 mg/kg and 200 mg/kg 
respectively showed significantly lower LDL values as compared to 
the diabetic control group. In contrast, HDL was the lowest in the 
diabetic control group with HDL value of 23.61±2.34 mg/dl. Groups 
IV and V which received treatment of plant extracts of 100 mg/kg 
and 200 mg/kg respectively showed significantly higher HDL values 
as compared to the diabetic control group. 
Histopathology examination 
Sections of the pancreas of rats from each group were stained with 
haematoxylin and eosin (H and E) and examined under the 
microscope (FSX 100 fluorescence microscope, Tokyo, Japan). Islets 
of Langerhans displaying degenerative and damaged acinar cells 
were seen in diabetic control fig. 1 C, D. However, most of the 
changes were alleviated by pretreatment of animals with O. 
corymbosa as shown in fig. 2 C, D, E and F. 
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Table 8: Effect of treatment of alloxan-induced diabetic rats with aqueous extract of O. corymbosa for 14 d on total cholesterol, LDL and HDL 
Group (n=3) Treatment Total cholesterol (mg/dl) LDL (mg/dl) HDL (mg/dl) 
I Normal control 98.09±1.56 51.97±1.59 35.48±3.13 
II Diabetic control 152.49±0.95* 165.83±1.00* 23.61±2.34* 
III Normal+O. corymbosa (200 mg/kg) 112.93±4.64** 65.49±3.16** 34.19±2.52** 
IV Diabetic+O. corymbosa (100 mg/kg) 127.9±6.52** 123.35±4.50** 32.42±1.25** 
V Diabetic+O. corymbosa (200 mg/kg) 92.56±5.49** 115.71±3.20** 34.47±1.67** 
Data are presented as mean±SD, *Significant value at P<0.05 compared to Normal control, **Significant value at P<0.05 compared to Diabetic control  
 
 
Fig. 1: Haematoxylin and eosin (H and E) stained histopathological sections of the pancreas after 14 d of treatment. (A) Normal control 
with 20X magnification: Native architecture of islets and pancreatic tissue. (B) Normal control with 40X magnification. (C) Diabetic 
control with 20X magnification on Islets of Langerhans displaying degenerative and damaged acinar cells can be seen. (D) Diabetic 
control with 40X magnification, I: Islets of Langerhans; A: Acinar cells; Blue arrow: Red blood cells; Green arrow: β-cells 
 
 
Fig. 2: Haematoxylin and eosin (H and E) stained histopathological sections of the pancreas after 14 d of treatment. (A) Plant control with 
20X magnification: Native architecture of islets and pancreatic tissue. (B) Plant control with 40X magnification. (C) Diabetic+100 mg/kg 
O. corymbosa extract with 20X magnification: Islets of Langerhans showing evenly distributed β-cells with an increased number of β-cells. 
Red blood cells were spotted and the acini cells appeared to be normal. (D) Diabetic+100 mg/kg O. corymbosa extract with 40X 
magnification. (E) Diabetic+200 mg/kg O. corymbosa extract with 20X magnification. Islets of Langerhans showing evenly distributed β-
cells with an increased number of β-cells. Red blood cells were spotted and the acini cells appeared to be normal. (F) Diabetic+200 mg/kg 
O. corymbosa extract with 40X magnification, I: Islets of Langerhans; A: Acinar cells; Blue arrow: Red blood cells; Green arrow: β-cells 
Iqbal et al. 




Phytochemicals can be defined as a large group of plant-derived 
compounds which can benefit the human-kind in health improvement 
and diseases prevention against several diseases such as diabetes and 
cancer [23, 24]. Based on the results obtained in this study, O. 
corymbosa showed the presence of tannins, phlobatannins, saponins 
and flavonoids as of its phytochemical constituents and possesses 
antioxidant activity and this result is also supported by previous 
studies conducted by Fatema and Hossain [12]. Various studies have 
been shown that medicinal plants possess anti-diabetic properties in 
search of cure or treatment for diabetes that has little side effects. 
Thus, the present study was undertaken to demonstrate the anti-
diabetic effect of O. corymbosa in alloxan-induced diabetic rats.  
In the present study, a significant elevation of blood glucose and a 
decrease in body weight were observed after alloxan injection. The 
decrease in body weight in diabetic induced rats was due to the 
process known as catabolism of fats and proteins [25] and may be 
caused by stress and deranged metabolism which leads to anorexia 
and reduced digestion [26]. The administration of aqueous extract of 
O. corymbosa to diabetic rats showed increased in body weight as 
compared to diabetic control rats which according to Balamurugan 
et al. [25] this is a positive indicator in which the plant has a 
preventive effect on the degradation of structural proteins [25] and 
also the plant studied in this current research might have the ability 
to control muscle wasting [27]. The elevation of blood glucose level 
in diabetic induced rats after administration of alloxan may be 
caused by the reduction of insulin production by β-cells of pancreas 
or insulin resistance in peripheral tissues [25, 26]. In the present 
study, the aqueous extract of O. corymbosa was found to reduce the 
blood glucose levels in diabetic rats and showed no effect on blood 
glucose of normal rats. The hypoglycaemic action of O. corymbosa 
may be due to the increase in the activities of the enzymes which 
responsible in the utilization of glucose by insulin-dependent 
pathway or regeneration of damaged β-cells in the pancreas [28]. 
The hypoglycaemic effect of O. corymbosa may be attributed to the 
bioactive compounds present in it. Khan et al. [26] suggested that 
the presence of bioactive ingredients in plant extracts is responsible 
in the anti-hyperglycaemic effect of herbal plants which causes 
restoration of pancreatic tissues function.  
Increase in the levels of LPO was observed in the diabetic induced 
rats. An increase in the levels of LPO in the diabetic induced rats may 
be due to the increase in oxidative stress in the cells which resulted 
from depletion of antioxidant scavenger systems [29]. In the current 
study, a significant decrease in LPO levels was observed in diabetic 
rats that received 100 mg/kg and 200 mg/kg of O. corymbosa 
extracts respectively as compared to the diabetic control group. This 
might be due to the antiperoxidative effect of bioactive compounds 
present in O. corymbosa which inhibit the oxidative damage. 
Concomitantly, a decrease in GSH and catalase activity was observed 
in the diabetic rats. The results presented in this study are in 
agreement with the other authors where they also reported 
decreased levels of GSH in diabetic rats [29, 30]. A significant 
elevation of GSH levels and catalase in diabetic induced rats were 
observed after treatment with O. corymbosa extracts might be due to 
its protective efficacy.  
Lipids play an important role in the pathogenesis of diabetes [31]. 
Significant elevation of total cholesterol (TC) and low-density 
lipoprotein (LDL) with a decreased level of high-density lipoprotein 
(HDL) are usually observed in diabetes cases and such conditions 
represent a risk factor for coronary heart disease [32]. The 
significantly high levels of TC and LDL as compared to normal 
control rats, may be due to the deficiency or absence of insulin as 
insulin functions to disturb in the regulation of the activity of the 
hormone-sensitive enzyme, lipase which is responsible in converting 
triglycerides to free fatty acids and glycerol [33]. On administration 
of aqueous extract of O. corymbosa to the diabetic rats, a significant 
reduction on the TC and LDL levels were observed. Khan et al. [26] 
reported that the presence of phenolic and flavonoids compounds in 
the extracts have a positive correlation with the reduction in blood 
glucose level as well as a lipid profile. The restoration of the TC, LDL 
and HDL values near to or at normal values could be attributed with 
bioactive compounds present in O. corymbosa. The histopathological 
examination undertaken on the pancreas has also shown recovery of 
the damaged and ruptured islet as well as an increase in the number 
of β-cells after treatment with O. corymbosa extracts.  
CONCLUSION 
Our data suggest that aqueous extract of O. corymbosa at a dose of 
100 mg/kg and 200 mg/kg body weight lowers blood glucose and 
lipid parameters except HDL. Significant restoration in GSH, LPO and 
CAT was observed in dose dependent manner. Histopathological 
examination of pancreatic sections revealed that diabetic rats 
treated with O. corymbosa extracts at either dose have normal 
architecture structure of islets. These results indicate that O. 
corymbosa may be effective as a hypoglycaemic and 
antihyperlipidemic agent. 
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